MGRX Stock Price, Chart, Stats & News

Mangoceuticals, Inc.
Save
3.21M
Market cap
–
Current P/E
–
Forward P/E
MGRX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 60.61% |
Operating margin | -4142.70% |
Pretax margin | -4245.61% |
Net margin | -4245.25% |
Effective tax rate | – |
ROA | -119.90% |
ROE | -114.62% |
D/E | 0.01x |
Interest coverage ratio | 54.79x |
MGRX valuation
P/E | – |
P/S | 11.94x |
P/B | 0.36x |
P/CF | -0.95x |
P/FCF | -0.94x |
P/OCF | -0.95x |
PEG | -0.03x |
EV multiple | -0.32x |
About
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand.
Similar securities
Based on sector and market capitalization
Report issue











